This text is a result of machine translation.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Putin will soon visit Central Asia and attend the Caspian summit, which is the first visit since the conflict between Russia and Ukraine
China Evergrande: it is expected to announce the preliminary restructuring plan at the end of July
Tianci materials: it is planned to buy back the company's shares of RMB 250million to RMB 500million
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Evergrande real estate was enforced for another 4.183 billion yuan
Lithium battery stocks continued to strengthen, and Edison raised the sealing plate
Another Chinese EV Startup Turns Profitable in China’s RMB 5 Trillion Auto Market
May 06, 2026 12:05 PM
AIFC Governor Renat Bekturov: Kazakhstan Is the Gateway for Chinese Capital Moving West
Apr 30, 2026 03:33 PM